University of Hertfordshire

From the same journal

By the same authors

Documents

  • Katherine M Livingstone
  • Carlos Celis-Morales
  • Santiago Navas-Carretero
  • Rodrigo San-Cristobal
  • Anna L Macready
  • Rosalind Fallaize
  • Hannah Forster
  • Clara Woolhead
  • Clare B O'Donovan
  • Cyril Fm Marsaux
  • Silvia Kolossa
  • Lydia Tsirigoti
  • Christina P Lambrinou
  • George Moschonis
  • Magdalena Godlewska
  • Agnieszka Surwiłło
  • Christian A Drevon
  • Yannis Manios
  • Iwona Traczyk
  • Eileen R Gibney
  • Lorraine Brennan
  • Marianne C Walsh
  • Julie A Lovegrove
  • Wim H Saris
  • Hannelore Daniel
  • Mike Gibney
  • J Alfredo Martinez
  • John C Mathers
  • Food4Me Study
View graph of relations
Original languageEnglish
Pages (from-to)288-97
Number of pages10
JournalThe American journal of clinical nutrition
Volume104
Issue2
Early online date29 Jun 2016
DOIs
Publication statusPublished - 1 Aug 2016

Abstract

BACKGROUND: Little is known about the efficacy of personalized nutrition (PN) interventions for improving consumption of a Mediterranean diet (MedDiet).

OBJECTIVE: The objective was to evaluate the effect of a PN intervention on dietary changes associated with the MedDiet.

DESIGN: Participants (n = 1607) were recruited into a 6-mo, Internet-based, PN randomized controlled trial (Food4Me) designed to evaluate the effect of PN on dietary change. Participants were randomly assigned to receive conventional dietary advice [control; level 0 (L0)] or PN advice on the basis of current diet [level 1 (L1)], diet and phenotype [level 2 (L2)], or diet, phenotype, and genotype [level 3 (L3)]. Dietary intakes from food-frequency questionnaires at baseline and at 6 mo were converted to a MedDiet score. Linear regression compared participant characteristics between high (>5) and low (≤5) MedDiet scores. Differences in MedDiet scores between treatment arms at month 6 were evaluated by using contrast analyses.

RESULTS: At baseline, high MedDiet scorers had a 0.5 lower body mass index (in kg/m(2); P = 0.007) and a 0.03 higher physical activity level (P = 0.003) than did low scorers. MedDiet scores at month 6 were greater in individuals randomly assigned to receive PN (L1, L2, and L3) than in controls (PN compared with controls: 5.20 ± 0.05 and 5.48 ± 0.07, respectively; P = 0.002). There was no significant difference in MedDiet scores at month 6 between PN advice on the basis of L1 compared with L2 and L3. However, differences in MedDiet scores at month 6 were greater in L3 than in L2 (L3 compared with L2: 5.63 ± 0.10 and 5.38 ± 0.10, respectively; P = 0.029).

CONCLUSIONS: Higher MedDiet scores at baseline were associated with healthier lifestyles and lower adiposity. After the intervention, MedDiet scores were greater in individuals randomly assigned to receive PN than in controls, with the addition of DNA-based dietary advice resulting in the largest differences in MedDiet scores. Although differences were significant, their clinical relevance is modest. This trial was registered at clinicaltrials.gov as NCT01530139.

Notes

The final, definitive version of this paper has been published in The American Journal of Clinical Nutrition, August 2016, Vol. 104 (2): 288-297, first published on line on June 29, 2016, it is available on line at doi: 10.3945/​ajcn.115.129049. © 2016 American Society for Nutrition.

ID: 10385475